<h4>Background</h4>Patients with indolent systemic mastocytosis (ISM), a clonal mast cell disease primarily driven by the KIT D816V mutation, often have lifelong debilitating symptoms. Here, KIT is linked to maculopapular cutaneous mastocytosis.